T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis
Sign Up to like & getrecommendations! Published in 2021 at "Biomedicines"
DOI: 10.3390/biomedicines9070772
Abstract: Although bronchiectasis pathophysiology has been historically understood around the presence of airway neutrophilic inflammation, recent experiences are consistent with the identification of a type 2 inflammation (T2) high endotype in bronchiectasis. In order to evaluate… read more here.
Keywords: bronchiectasis patients; biological treatments; bronchiectasis; response ... See more keywords